Literature DB >> 1647928

Resting energy expenditure in chronic cardiac failure.

M Riley1, J S Elborn, W R McKane, N Bell, C F Stanford, D P Nicholls.   

Abstract

1. Resting energy expenditure has previously been shown to be elevated in the acute phase of heart failure, but the situation in the compensated state of chronic cardiac failure is unclear. Resting energy expenditure was assessed in 14 patients with stable chronic cardiac failure and 14 matched control subjects by using indirect calorimetry. 2. Resting energy expenditure was significantly elevated in the patients with chronic cardiac failure (112.6 +/- 18.1 versus 87.1 +/- 12.2 kJ day-1 kg-1 total body weight, P less than 0.0002; mean +/- SD) as were resting O2 consumption (3.88 +/- 0.64 versus 3.00 +/- 0.43 ml min-1 kg-1, P less than 0.0002), ventilation (164 +/- 40.3 versus 104 +/- 16.2 ml min-1 kg-1, P less than 0.0001) and heart rate (85.8 +/- 16.9 versus 66.6 +/- 6.9 beats/min, P less than 0.001). Both the resting plasma concentration of noradrenaline (4.48 +/- 1.52 versus 2.28 +/- 0.96 nmol/l, P less than 0.0001) and the serum concentration of free fatty acids (0.78 +/- 0.21 versus 0.57 +/- 0.27 mmol/l, P less than 0.03) were greater in the patients with chronic cardiac failure. Analysis of covariance indicated that most of the difference in resting energy expenditure could be accounted for by the elevated ventilation in the patients with chronic cardiac failure. Arm muscle area, an index of wasting, was lower in the patients with chronic cardiac failure (39.1 +/- 13.1 versus 50.5 +/- 9.4 cm2, P less than 0.02) and resting energy expenditure was found to account for some of this difference. 3. We conclude that an elevated basal metabolism occurs in chronic cardiac failure.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1647928     DOI: 10.1042/cs0800633

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  10 in total

1.  The endeavor of high maintenance homeostasis: resting metabolic rate and the legacy of longevity.

Authors:  Carmelinda Ruggiero; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-05       Impact factor: 6.053

2.  Inappropriately low plasma leptin concentration in the cachexia associated with chronic heart failure.

Authors:  D R Murdoch; E Rooney; H J Dargie; D Shapiro; J J Morton; J J McMurray
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

3.  Pain Energy Model of Mobility Limitation in the Older Adult.

Authors:  Peter C Coyle; Jennifer A Schrack; Gregory E Hicks
Journal:  Pain Med       Date:  2018-08-01       Impact factor: 3.750

Review 4.  Neuroendocrine changes in chronic cardiac failure.

Authors:  D P Nicholls; G N Onuoha; G McDowell; J S Elborn; M S Riley; A M Nugent; I C Steele; C Shaw; K D Buchanan
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

5.  Deranged Cardiac Metabolism and the Pathogenesis of Heart Failure.

Authors:  Gabriele Fragasso
Journal:  Card Fail Rev       Date:  2016-05

Review 6.  The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism.

Authors:  Mark D DeBoer
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

7.  Tumour necrosis factor alpha in severe congestive cardiac failure.

Authors:  D P Dutka; J S Elborn; F Delamere; D J Shale; G K Morris
Journal:  Br Heart J       Date:  1993-08

8.  Gas exchange responses to constant work rate exercise in chronic cardiac failure.

Authors:  M Riley; J Pórszász; C F Stanford; D P Nicholls
Journal:  Br Heart J       Date:  1994-08

9.  Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.

Authors:  Rosita Zakeri; Barry A Borlaug; Steven E McNulty; Selma F Mohammed; Gregory D Lewis; Marc J Semigran; Anita Deswal; Martin LeWinter; Adrian F Hernandez; Eugene Braunwald; Margaret M Redfield
Journal:  Circ Heart Fail       Date:  2013-10-25       Impact factor: 8.790

10.  Metabolic and respiratory consequences of a glucose load in a hypoxic patient with cystic fibrosis.

Authors:  J S Elborn; T Jagoe; D J Shale
Journal:  Ulster Med J       Date:  1992-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.